Fifteen patients (78.9%) were male, 9 (47.4%) had non-viral HCC, 15 (78.9%) had Barcelona Clinic Liver Cancer stage C, and median alpha fetoprotein (AFP) was 885 ng/mL (range, 2.1–625,505 ng/mL). This evidence concerns the gene AFP and liver cancer.